developmental epileptic encephalopathy

Copenhagen, Denmark, September 15, 2026 H. Lundbeck A/S has announced that the last patient has been randomized in DEEp...

SAN DIEGO, May 8, 2026 Actio Biosciences announced the initiation of the KYRON Phase 1b/2 clinical trial evaluating ABS-1230,...